Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INCexhibit99_1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

______________________________


FORM 8-K


CURRENT REPORT
Pursuant To Section 13 or 15(d) of The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported)   June 22, 2011 (June 22, 2011)   



VANGUARD HEALTH SYSTEMS, INC.
(Exact name of registrant as specified in its charter)

          DELAWARE          

 

               333-71934                 

 

          62-1698183          

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification Number)


20 Burton Hills Boulevard, Suite 100, Nashville, Tennessee

 


     37215     

(Address of principal executive offices)

 

(Zip Code)

Registrant’s Telephone Number, including area code        (615) 665-6000     

          Not applicable          
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

______________________________


Item 8.01

   

Other Events.

 

 

 

 

  

On June 22, 2011, Vanguard Health Systems, Inc. ( the “Company”) issued a press release announcing pricing of its initial public offering of 25,000,000 shares of common stock.  For information regarding this matter, the Company hereby incorporates by reference herein the information set forth in its Press Release dated June 22, 2011, a copy of which is attached hereto as Exhibit 99.1.

 

 

 

 

Item 9.01

   

Financial Statements and Exhibits.

 

 

 

 

 

(d)     

Exhibits.

The exhibits filed as part of this report are listed in the Exhibit Index which is located at the end of this report.

-2-



SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DATE:   June 22, 2011                                     VANGUARD HEALTH SYSTEMS, INC.
                                                                                                (Registrant)

                                                                        BY: /s/ Ronald P. Soltman                                           
                                                                               Ronald P. Soltman
                                                                               Executive Vice President, General Counsel
                                                                               & Secretary

-3-



VANGUARD HEALTH SYSTEMS, INC.

EXHIBIT INDEX

Exhibit No.

   

Description

 

 

 

99.1

 

Press Release of Vanguard Health Systems, Inc. dated June 22, 2011 announcing pricing of its initial public offering of  common stock.

-4-